STOCK TITAN

Firsthand Technology Value Fund Discloses Top Portfolio Holdings

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

As of May 31, 2022, Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five holdings, which comprise 92.4% of its estimated total investments of approximately $66.8 million. These include IntraOp Medical (32.2%), Wrightspeed (28.5%), Revasum (17.5%), Hera Systems (9.4%), and Pivotal Systems (4.9%). The Fund's estimated value per share stands at $9.70, with cash and equivalents at approximately $0.27 per share. A comprehensive financial report will be available in August 2022.

Positive
  • Top five holdings represent 92.4% of estimated total investments.
  • Fund's estimated total investments at $66.8 million.
  • Estimated value per share is $9.70.
Negative
  • None.

SAN JOSE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Firsthand Technology Value Fund, Inc. (NASDAQ: SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its top five holdings as of May 31, 2022, were IntraOp Medical, Wrightspeed, Revasum, Hera Systems, and Pivotal Systems.

1.IntraOp Medical Corp. is the manufacturer of the Mobetron, a medical device that is used to deliver intra-operative radiation to cancer patients. As of May 31, 2022, the Fund’s investment in IntraOp consisted of 26,856,187 shares of preferred stock plus debt securities and represented approximately 32.2% of the Fund’s estimated total investments.*
  
2.Wrightspeed, Inc. is a supplier of electric drivetrains for heavy-duty commercial vehicles. As of May 31, 2022, the Fund’s investment in Wrightspeed consisted of 60,802,795 shares of preferred and common stock plus debt securities and warrants to purchase additional shares, and represented approximately 28.5% of the Fund’s estimated total investments.*
  
3.Revasum, Inc. (ASX: RVS) is a provider of chemical-mechanical planarization (CMP) and grinding tools to the semiconductor industry. As of May 31, 2022, the Fund’s investment in Revasum consisted of 39,744,889 shares of common stock equivalents (CDI’s) and represented approximately 17.5% of the Fund’s estimated total investments.*
  
4.Hera Systems, Inc. is developing micro satellites with imaging and communication capabilities for launch into low Earth orbit. As of May 31, 2022, the Fund’s investment in Hera consisted of 13,331,527 shares of preferred stock plus debt securities and warrants to purchase additional shares and represented approximately 9.4% of the Fund’s estimated total investments.*
  
5.Pivotal Systems Corp. (ASX: PVS) provides monitoring and process control technologies for the semiconductor manufacturing industry. As of May 31, 2022, the Fund’s investment in Pivotal consisted of 13,738,824 shares of common stock equivalents (CDI’s) and represented approximately 4.9% of the Fund’s estimated total investments.*

The Fund also announced that as of May 31, 2022, the estimated total investments* of the Fund were approximately $66.8 million, or $9.70 per share, including cash and cash equivalents of approximately $0.27 per share. As of that date, the Fund’s top five holdings constituted 92.4% of the Fund’s estimated total investments.* Complete financial statements and a detailed schedule of investments as of June 30, 2022, will be available in the Fund’s quarterly report filing on Form 10-Q in August 2022.

*Total investments are estimated as of May 31, 2022, and represent the value of the Fund’s total investments as of March 31, 2022, plus the estimated net change in unrealized appreciation/depreciation and actual realized gains/losses on publicly traded and private securities since March 31, 2022. For the purposes of calculating the percentage of estimated total investments represented by each investment, the value of each holding is determined by either: (1) the purchase price, (2) the market value for public securities, less any discounts taken due to restrictions on the stock, or (3) the March 31, 2022, fair value of each security, as determined under procedures approved by our Board of Directors. The estimated total investments figure does not reflect net asset value because actual and estimated liabilities (such as estimated tax liabilities and performance fees, accrued vendor service fees and other liabilities) are not deducted.

About Firsthand Technology Value Fund
Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund that invests in technology and cleantech companies. More information about the Fund and its holdings can be found online at www.firsthandtvf.com.

The Fund is a non-diversified, closed-end investment company that elected to be treated as a business development company under the Investment Company Act of 1940. The Fund’s investment objective is to seek long-term growth of capital. Under normal circumstances, the Fund will invest at least 80% of its total assets for investment purposes in technology and cleantech companies. An investment in the Fund involves substantial risks, some of which are highlighted below. Unlike most business development companies, the Fund is taxed as a corporation rather than a Regulated Investment Company under federal tax laws, based on the composition of its assets. Please see the Fund’s public filings for more information about fees, expenses and risk. Past investment results do not provide any assurances about future results.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to materially differ from the Fund’s historical experience and its present expectations or projections indicated in any forward-looking statement. These risks include, but are not limited to, changes in economic and political conditions, regulatory and legal changes, technology and cleantech industry risk, valuation risk, non-diversification risk, interest rate risk, tax risk, and other risks discussed in the Fund’s filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund’s investment objectives will be attained. We acknowledge that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as us.

Contact:

Phil Mosakowski
Firsthand Capital Management, Inc.
(408) 624-9526
vc@firsthandtvf.com 


FAQ

What are the top holdings of SVVC as of May 31, 2022?

The top holdings of SVVC include IntraOp Medical, Wrightspeed, Revasum, Hera Systems, and Pivotal Systems.

What is the estimated total investment value of SVVC?

SVVC's estimated total investment value is approximately $66.8 million.

What is the estimated value per share for SVVC?

The estimated value per share for SVVC is $9.70.

When will the detailed financial statements for SVVC be available?

The complete financial statements will be available in the Fund's quarterly report filing on Form 10-Q in August 2022.

FIRSTHAND TEC VAL FUND

OTC:SVVC

SVVC Rankings

SVVC Latest News

SVVC Stock Data

413.58k
38.75%
0.1%
0.38%
Asset Management
Financial Services
Link
United States of America
San Jose